Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study.

Yoo DH, Prodanovic N, Jaworski J, Miranda P, Ramiterre E, Lanzon A, Baranauskaite A, Wiland P, Abud-Mendoza C, Oparanov B, Smiyan S, Kim H, Lee SJ, Kim S, Park W.

Ann Rheum Dis. 2016 Apr 29. pii: annrheumdis-2015-208786. doi: 10.1136/annrheumdis-2015-208786. [Epub ahead of print]

2.

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.

Park W, Yoo DH, Miranda P, Brzosko M, Wiland P, Gutierrez-Ureña S, Mikazane H, Lee YA, Smiyan S, Lim MJ, Kadinov V, Abud-Mendoza C, Kim H, Lee SJ, Bae Y, Kim S, Braun J.

Ann Rheum Dis. 2016 Apr 26. pii: annrheumdis-2015-208783. doi: 10.1136/annrheumdis-2015-208783. [Epub ahead of print]

3.

[Immunological markers of rheumatoid arthritis].

Matuszewska A, Madej M, Wiland P.

Postepy Hig Med Dosw (Online). 2016 Mar 25;70:251-7. doi: 10.5604/17322693.1198270. Polish.

PMID:
27117100
4.

Disease Activity, Oxidized-LDL Fraction and Anti-Oxidized LDL Antibodies Influence Cardiovascular Risk in Rheumatoid Arthritis.

Nowak B, Madej M, Łuczak A, Małecki R, Wiland P.

Adv Clin Exp Med. 2016 Jul-Aug;25(1):43-50. doi: 10.17219/acem/29847.

5.

Activity of JAK/STAT and NF-kB in patients with axial spondyloarthritis.

Świerkot J, Sokolik R, Czarny A, Zaczyńska E, Nowak B, Chlebicki A, Korman L, Madej M, Wojtala P, Lubiński Ł, Wiland P.

Postepy Hig Med Dosw (Online). 2015 Dec 2;69:1291-8.

6.

Reported concepts for the treatment modalities and pain management of temporomandibular disorders.

Wieckiewicz M, Boening K, Wiland P, Shiau YY, Paradowska-Stolarz A.

J Headache Pain. 2015;16:106. doi: 10.1186/s10194-015-0586-5. Epub 2015 Dec 7. Review.

7.

Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment.

Iwaszko M, Świerkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K.

Joint Bone Spine. 2016 Jan;83(1):75-9. doi: 10.1016/j.jbspin.2015.06.010. Epub 2015 Oct 6.

PMID:
26453102
8.

Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy.

Iwaszko M, Świerkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K.

Clin Exp Immunol. 2015 Dec;182(3):270-7. doi: 10.1111/cei.12696. Epub 2015 Sep 28.

PMID:
26307125
9.

Endogenous event-related potentials in patients with primary Sjögren's syndrome without central nervous system involvement.

Dziadkowiak E, Sebastian A, Wiland P, Waliszewska-Prosół M, Wieczorek M, Zagrajek M, Ejma M.

Scand J Rheumatol. 2015;44(6):487-94. doi: 10.3109/03009742.2015.1032345. Epub 2015 Aug 14.

PMID:
26271272
10.

Pregnancy exacerbates complications of acquired hemophilia in a patient with systemic lupus erythematosus.

Sebastian A, Misterska-Skóra M, Podolak-Dawidziak M, Szmyrka-Kaczmarek M, Sebastian M, Wiland P.

Postepy Dermatol Alergol. 2015 Jun;32(3):235-8. doi: 10.5114/pdia.2014.40964. Epub 2015 Jun 15. No abstract available.

11.

Temporomandibular disorders and oral parafunctions: mechanism, diagnostics, and therapy.

Boening K, Wieckiewicz M, Paradowska-Stolarz A, Wiland P, Shiau YY.

Biomed Res Int. 2015;2015:354759. doi: 10.1155/2015/354759. Epub 2015 May 14. No abstract available.

12.

Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis.

Świerkot J, Gruszecka K, Matuszewska A, Wiland P.

Arch Immunol Ther Exp (Warsz). 2015 Oct;63(5):397-404. doi: 10.1007/s00005-015-0338-x. Epub 2015 Apr 3.

13.

Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.

Świerkot J, Ślęzak R, Karpiński P, Pawłowska J, Noga L, Szechiński J, Wiland P.

Pol Arch Med Wewn. 2015;125(3):152-61. Epub 2015 Jan 19.

14.

Significance of association of HLA-C and HLA-E with psoriatic arthritis.

Sokolik R, Gębura K, Iwaszko M, Świerkot J, Korman L, Wiland P, Bogunia-Kubik K.

Hum Immunol. 2014 Dec;75(12):1188-91. doi: 10.1016/j.humimm.2014.10.005. Epub 2014 Oct 16.

PMID:
25454626
15.

IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis.

Bogunia-Kubik K, Świerkot J, Malak A, Wysoczańska B, Nowak B, Białowąs K, Gębura K, Korman L, Wiland P.

Arch Immunol Ther Exp (Warsz). 2015 Jun;63(3):215-21. doi: 10.1007/s00005-014-0319-5. Epub 2014 Nov 12.

16.

Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis.

Swierkot J, Bogunia-Kubik K, Nowak B, Bialowas K, Korman L, Gebura K, Kolossa K, Jeka S, Wiland P.

Joint Bone Spine. 2015 Mar;82(2):94-9. doi: 10.1016/j.jbspin.2014.08.006. Epub 2014 Oct 11.

PMID:
25311255
17.

Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.

Szmyrka-Kaczmarek M, Kosmaczewska A, Ciszak L, Szteblich A, Wiland P.

Postepy Hig Med Dosw (Online). 2014;68:893-8.

18.

Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries.

Péntek M, Poór G, Wiland P, Olejárová M, Brzosko M, Codreanu C, Brodszky N, Gulácsi L.

Eur J Health Econ. 2014 May;15 Suppl 1:S35-43. doi: 10.1007/s10198-014-0592-6. Epub 2014 May 16. Review.

PMID:
24832834
19.

MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.

Behrens F, Tak PP, Østergaard M, Stoilov R, Wiland P, Huizinga TW, Berenfus VY, Vladeva S, Rech J, Rubbert-Roth A, Korkosz M, Rekalov D, Zupanets IA, Ejbjerg BJ, Geiseler J, Fresenius J, Korolkiewicz RP, Schottelius AJ, Burkhardt H.

Ann Rheum Dis. 2015 Jun;74(6):1058-64. doi: 10.1136/annrheumdis-2013-204816. Epub 2014 Feb 17.

20.

[Enhanced ocular staining score in patients with primary Sjögren's syndrome].

Sebastian A, Markuszewska A, Markuszewski B, Misiuk-Hojło M, Wiland P.

Klin Oczna. 2014;116(3):205-9. Review. Polish.

PMID:
25799786
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk